Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


23.12.2018

1 Br J Psychiatry
1 Compr Psychiatry
1 J Clin Psychopharmacol
1 J Int Neuropsychol Soc
1 J Psychiatry Neurosci
1 Mol Psychiatry
1 PLoS Genet
1 PLoS One
21 Psychiatry Res
3 Psychol Med
5 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Psychiatry

  1. BROWN HK, Dennis CL, Kurdyak P, Vigod SN, et al
    A population-based study of the frequency and predictors of induced abortion among women with schizophrenia.
    Br J Psychiatry. 2018 Dec 20:1-8. doi: 10.1192/bjp.2018.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  2. KESSLER T, Lev-Ran S
    The association between comorbid psychiatric diagnoses and hospitalization-related factors among individuals with schizophrenia.
    Compr Psychiatry. 2018;89:7-15.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  3. IVKOVIC J, Lindsten A, George V, Eriksson H, et al
    Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia.
    J Clin Psychopharmacol. 2019;39:13-19.
    PubMed     Text format     Abstract available


    J Int Neuropsychol Soc

  4. THOMAS EHX, Rossell SL, Myles JB, Tan EJ, et al
    Working Memory and Attention Influence Antisaccade Error Rate in Schizophrenia.
    J Int Neuropsychol Soc. 2018 Dec 18:1-10. doi: 10.1017/S1355617718001066.
    PubMed     Text format     Abstract available


    J Psychiatry Neurosci

  5. DONDAINE T, Philippot P, Batail JM, Le Jeune F, et al
    Apathy alters emotional arousal in chronic schizophrenia
    J Psychiatry Neurosci. 2019;:1.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  6. MITCHELL AC, Javidfar B, Pothula V, Ibi D, et al
    MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
    Mol Psychiatry. 2018;23:123-132.
    PubMed     Text format     Abstract available


    PLoS Genet

  7. NAGY S, Maurer GW, Hentze JL, Rose M, et al
    AMPK signaling linked to the schizophrenia-associated 1q21.1 deletion is required for neuronal and sleep maintenance.
    PLoS Genet. 2018;14:e1007623.
    PubMed     Text format     Abstract available


    PLoS One

  8. STEENHUIS LA, Nauta MH, Bockting CLH, Pijnenborg GHM, et al
    Correction: Treating Depressive Symptoms in Psychosis: A Network Meta-Analysis on the Effects of Non-Verbal Therapies.
    PLoS One. 2018;13:e0209762.
    PubMed     Text format     Abstract available


    Psychiatry Res

  9. MCCARTHY NS, Clark ML, Jablensky A, Badcock JC, et al
    No association between common genetic variation in FOXP2 and language impairment in schizophrenia.
    Psychiatry Res. 2018;271:590-597.
    PubMed     Text format     Abstract available

  10. DESTE G, Barlati S, Gregorelli M, Lisoni J, et al
    Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS).
    Psychiatry Res. 2018;270:764-768.
    PubMed     Text format     Abstract available

  11. CHEN LJ, Hao JC, Ku PW, Stubbs B, et al
    Prospective associations of physical fitness and cognitive performance among inpatients with Schizophrenia.
    Psychiatry Res. 2018;270:738-743.
    PubMed     Text format     Abstract available

  12. THIBODEAU R, Peterson KM
    On continuum beliefs and psychiatric stigma: Similarity to a person with schizophrenia can feel too close for comfort.
    Psychiatry Res. 2018;270:731-737.
    PubMed     Text format     Abstract available

  13. AHUIR M, Cabezas A, Minano MJ, Algora MJ, et al
    Improvement in cognitive biases after group psychoeducation and metacognitive training in recent-onset psychosis: A randomized crossover clinical trial.
    Psychiatry Res. 2018;270:720-723.
    PubMed     Text format     Abstract available

  14. CHUNG KF, Poon YPY, Ng TK, Kan CK, et al
    Correlates of sleep irregularity in schizophrenia.
    Psychiatry Res. 2018;270:705-714.
    PubMed     Text format     Abstract available

  15. LE TP, Holden JL, Link PC, Granholm EL, et al
    Neurocognitive and theory of mind deficits and poor social competence in schizophrenia: The moderating role of social disinterest attitudes.
    Psychiatry Res. 2018;270:459-466.
    PubMed     Text format     Abstract available

  16. BHAT NA, Sharma V, Kumar D
    Prospective memory in obsessive compulsive disorder.
    Psychiatry Res. 2018;261:124-131.
    PubMed     Text format     Abstract available

  17. ISHIDA T, Nakamura K, Miyazaki K, Yukawa T, et al
    Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review.
    Psychiatry Res. 2018 Dec 10. pii: S0165-1781(18)31786.
    PubMed     Text format    

  18. PAN J, Zhou Y, Xiang Y, Yu J, et al
    Retinal nerve fiber layer thickness changes in Schizophrenia: A meta-analysis of case-control studies.
    Psychiatry Res. 2018;270:786-791.
    PubMed     Text format     Abstract available

  19. BERNA F, Zou F, Danion JM, Kwok SC, et al
    Overconfidence in false autobiographical memories in patients with schizophrenia.
    Psychiatry Res. 2018 Dec 10. pii: S0165-1781(18)32123.
    PubMed     Text format    

  20. PHALEN PL, Rouhakhtar PR, Millman ZB, Thompson E, et al
    Validity of a two-item screen for early psychosis.
    Psychiatry Res. 2018;270:861-868.
    PubMed     Text format     Abstract available

  21. GAWEDA L, Krezolek M
    Cognitive mechanisms of alexithymia in schizophrenia: Investigating the role of basic neurocognitive functioning and cognitive biases.
    Psychiatry Res. 2018;271:573-580.
    PubMed     Text format     Abstract available

  22. KOELKEBECK K, Vosseler A, Kohl W, Fasshauer T, et al
    Masked ambiguity - Emotion identification in schizophrenia and major depressive disorder.
    Psychiatry Res. 2018;270:852-860.
    PubMed     Text format     Abstract available

  23. DURNA G, Yorulmaz O, Aktac A
    Public stigma of obsessive compulsive disorder and schizophrenic disorder: Is there really any difference?
    Psychiatry Res. 2018;271:559-564.
    PubMed     Text format     Abstract available

  24. GADEA M, Herrero N, Pico A, Espert R, et al
    Psychobiological response to an anger induction task in schizophrenia: The key role of anxiety.
    Psychiatry Res. 2018;271:541-547.
    PubMed     Text format     Abstract available

  25. HAZLETT EA, Vaccaro DH, Haznedar MM, Goldstein KE, et al
    (F-18)Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: The legacy of Monte S. Buchsbaum, M.D.
    Psychiatry Res. 2018;271:535-540.
    PubMed     Text format     Abstract available

  26. YUKAWA T, Iwakura Y, Takei N, Saito M, et al
    Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophrenia.
    Psychiatry Res. 2018;270:940-946.
    PubMed     Text format     Abstract available

  27. GRZECZKOWSKI L, Roinishvili M, Chkonia E, Brand A, et al
    Is the perception of illusions abnormal in schizophrenia?
    Psychiatry Res. 2018;270:929-939.
    PubMed     Text format     Abstract available

  28. TIBBER MS, Kirkbride JB, Joyce EM, Mutsatsa S, et al
    The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods.
    Psychiatry Res. 2018;270:869-879.
    PubMed     Text format     Abstract available

  29. RITSNER MS, Ratner Y, Mendyk N, Gooding DC, et al
    The characterization of social anhedonia and its correlates in schizophrenia and schizoaffective patients.
    Psychiatry Res. 2018;270:922-928.
    PubMed     Text format     Abstract available


    Psychol Med

  30. QUIDE Y, Bortolasci CC, Spolding B, Kidnapillai S, et al
    Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.
    Psychol Med. 2018 Dec 18:1-9. doi: 10.1017/S0033291718003690.
    PubMed     Text format     Abstract available

  31. EBDRUP BH, Axelsen MC, Bak N, Fagerlund B, et al
    Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naive schizophrenia patients.
    Psychol Med. 2018 Dec 18:1-10. doi: 10.1017/S0033291718003781.
    PubMed     Text format     Abstract available

  32. BUTLER R, Berry K, Varese F, Bucci S, et al
    Are family warmth and positive remarks related to outcomes in psychosis? A systematic review.
    Psychol Med. 2018 Dec 20:1-16. doi: 10.1017/S0033291718003768.
    PubMed     Text format     Abstract available


    Schizophr Res

  33. REKHI G, Ang MS, Yuen CKY, Ng WY, et al
    Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Schizophr Res. 2018 Dec 14. pii: S0920-9964(18)30681.
    PubMed     Text format     Abstract available

  34. PINHEIRO AP, Niznikiewicz M
    Altered attentional processing of happy prosody in schizophrenia.
    Schizophr Res. 2018 Dec 13. pii: S0920-9964(18)30675.
    PubMed     Text format     Abstract available

  35. DONDE C, Silipo G, Dias EC, Javitt DC, et al
    Hierarchical deficits in auditory information processing in schizophrenia.
    Schizophr Res. 2018 Dec 12. pii: S0920-9964(18)30692.
    PubMed     Text format     Abstract available

  36. ACHTYES ED, Ben-Zeev D, Luo Z, Mayle H, et al
    Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospital.
    Schizophr Res. 2018 Dec 11. pii: S0920-9964(18)30677.
    PubMed     Text format     Abstract available

  37. NORDGAARD J, Buch Pedersen M, Hastrup LH, Haahr UH, et al
    Assessing psychosis in the general population: Self-rated versus clinician-rated.
    Schizophr Res. 2018 Dec 14. pii: S0920-9964(18)30702.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: